Status:
COMPLETED
Nasal CPAP - The Treatment IMpact on Oxygenation in High-risk Patients During Deep Sedation for Endoscopy
Lead Sponsor:
Universitätsklinikum Hamburg-Eppendorf
Conditions:
Continuous Positive Airway Pressure
Endoscopy
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Deep sedation during gastrointestinal endoscopy in patients with cardiopulmonary risk factors such as respective co-morbidities or also morbid obesity is challenging. Those high-risk patients are at r...
Detailed Description
High risk patients were defined as American Society of Anaesthesiology (ASA) class \>3 and/or BMI ≥30 kg/m², in accordance with the current World Health Organization (WHO) definition of obesity schedu...
Eligibility Criteria
Inclusion
- Adult and obese high-risk patients (ASA class ≥3 and/or BMI ≥30 kg/m², in accordance with the current WHO definition of obesity) scheduled for elective gastrointestinal endoscopy with deep sedation.
Exclusion
- Age \< 18 years
- Pregnancy
- Cognitive impairment, that makes consent to study impossible
- Known but untreated heart disease (e.g. persistent foramen ovale (PFO), recent congestive heart failure), complicating comparability within groups
Key Trial Info
Start Date :
November 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2024
Estimated Enrollment :
158 Patients enrolled
Trial Details
Trial ID
NCT06168682
Start Date
November 1 2023
End Date
June 30 2024
Last Update
December 9 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Anesthesiology, Center of Anesthesiology and Intensive Care Medicine
Hamburg, Germany, 20246